View Full Image Donald Trump speaking at a December news conference, accompanied by Cantor Fitzgerald CEO Howard ... consultants are hosting their own cocktail parties and balls across Washington ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Prenetics Global Limited (NASDAQ:PRE – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Prenetics Global in a research note issued ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher Mining shares (NASDAQ:CIFR), with a set price target of $11.00. The firm's analyst, Brett Knoblauch, provided insight into ...

In a report released yesterday, C J Muse from Cantor Fitzgerald maintained a Hold rating on KLA (KLAC – Research Report), with a price target of $875.00. The company’s shares closed yesterday ...

Vertex's stock performance in the near term may be influenced by the outcome of the FDA's decision and the subsequent market reception ... for the launch, Cantor Fitzgerald hosted a discussion ...

Palantir Technologies Inc. (NASDAQ:PLTR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Palantir Technologies in a note issued to ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing Wednesday as he recalled the more than 650 employees — including his ...

In a report released yesterday, Colin Canfield from Cantor Fitzgerald maintained a Buy rating on Planet Labs PBC (PL – Research Report), with a price target of $6.30. The company’s shares ...

Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. As of January 29, 2025, the average one-year ...

Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (WBAG:LRC2) from Neutral to Overweight. There are 1,883 funds or institutions reporting positions ...